APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 57 filers reported holding APPLIED MOLECULAR TRANS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 2.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,024 | -60.9% | 866,392 | -35.8% | 0.00% | – |
| Q2 2023 | $348,265 | -19.5% | 1,349,867 | -0.1% | 0.00% | – |
| Q1 2023 | $432,366 | -23.8% | 1,351,143 | 0.0% | 0.00% | – |
| Q4 2022 | $567,480 | -56.8% | 1,351,143 | +0.0% | 0.00% | – |
| Q3 2022 | $1,314,000 | -52.8% | 1,350,774 | +41.4% | 0.00% | – |
| Q2 2022 | $2,781,000 | -60.3% | 955,574 | +2.6% | 0.00% | – |
| Q1 2022 | $7,002,000 | -51.5% | 931,103 | -9.8% | 0.00% | – |
| Q4 2021 | $14,433,000 | -46.1% | 1,032,416 | -0.3% | 0.00% | -100.0% |
| Q3 2021 | $26,778,000 | -44.0% | 1,035,112 | -1.0% | 0.00% | 0.0% |
| Q2 2021 | $47,825,000 | +24.1% | 1,045,586 | +19.4% | 0.00% | 0.0% |
| Q1 2021 | $38,535,000 | +101.4% | 875,603 | +40.9% | 0.00% | 0.0% |
| Q4 2020 | $19,129,000 | +5.2% | 621,635 | +8.8% | 0.00% | 0.0% |
| Q3 2020 | $18,187,000 | +1969.1% | 571,573 | +1533.1% | 0.00% | – |
| Q2 2020 | $879,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund V Management, LLC | 3,611,615 | $567,024 | 70.62% |
| Founders Fund VI Management, LLC | 826,607 | $129,777 | 0.98% |
| EPIQ Capital Group, LLC | 8,689,075 | $1,364,185 | 0.71% |
| GEODE CAPITAL MANAGEMENT, LLC | 139,808 | $21,949 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $78 | 0.00% |
| STATE STREET CORP | 55,055 | $8,644 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 650 | $0 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 49,958 | $7,843 | 0.00% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 66,207 | $10,395 | 0.00% |
| Qube Research & Technologies Ltd | 2,104 | $330 | 0.00% |